These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 37612282)
41. ALKBH5 prevents hepatocellular carcinoma progression by post-transcriptional inhibition of PAQR4 in an m6A dependent manner. Wang W; Huang Q; Liao Z; Zhang H; Liu Y; Liu F; Chen X; Zhang B; Chen Y; Zhu P Exp Hematol Oncol; 2023 Jan; 12(1):1. PubMed ID: 36609413 [TBL] [Abstract][Full Text] [Related]
42. RNA demethylase ALKBH5 promotes colorectal cancer progression by posttranscriptional activation of RAB5A in an m6A-YTHDF2-dependent manner. Shen D; Lin J; Xie Y; Zhuang Z; Xu G; Peng S; Tang G; Bai L; Zhu M; Zhang Y; Huang Z; Wang P; Liu X; Huang M; Luo Y; Wang X; Yu H Clin Transl Med; 2023 May; 13(5):e1279. PubMed ID: 37203239 [TBL] [Abstract][Full Text] [Related]
43. MiR-141-3p promotes malignant progression in prostate cancer through AlkB homolog 5-mediated m Li X; Liu B; Wang S; Li J; Ge X Chin J Physiol; 2023; 66(1):43-51. PubMed ID: 36814156 [TBL] [Abstract][Full Text] [Related]
44. ALKBH5 inhibits the SIRT3/ACC1 axis to regulate fatty acid metabolism via an m6A-IGF2BP1-dependent manner in cervical squamous cell carcinoma. Zhen L; Pan W Clin Exp Pharmacol Physiol; 2023 May; 50(5):380-392. PubMed ID: 36705046 [TBL] [Abstract][Full Text] [Related]
45. ALKBH5-Mediated m6A Demethylation of GLUT4 mRNA Promotes Glycolysis and Resistance to HER2-Targeted Therapy in Breast Cancer. Liu H; Lyu H; Jiang G; Chen D; Ruan S; Liu S; Zhou L; Yang M; Zeng S; He Z; Wang H; Li H; Zheng G; Liu B Cancer Res; 2022 Nov; 82(21):3974-3986. PubMed ID: 36069931 [TBL] [Abstract][Full Text] [Related]
46. Suppression of m6A mRNA modification by DNA hypermethylated ALKBH5 aggravates the oncological behavior of KRAS mutation/LKB1 loss lung cancer. Zhang D; Ning J; Okon I; Zheng X; Satyanarayana G; Song P; Xu S; Zou MH Cell Death Dis; 2021 May; 12(6):518. PubMed ID: 34016959 [TBL] [Abstract][Full Text] [Related]
47. ALKBH5 promotes the progression of infantile hemangioma through regulating the NEAT1/miR-378b/FOSL1 axis. Peng K; Xia RP; Zhao F; Xiao Y; Ma TD; Li M; Feng Y; Zhou CG Mol Cell Biochem; 2022 May; 477(5):1527-1540. PubMed ID: 35182329 [TBL] [Abstract][Full Text] [Related]
48. ALKBH5 activates FAK signaling through m6A demethylation in Sun R; Yuan L; Jiang Y; Wan Y; Ma X; Yang J; Sun G; Zhou S; Wang H; Qiu J; Zhang L; Cheng W Theranostics; 2023; 13(2):833-848. PubMed ID: 36632222 [No Abstract] [Full Text] [Related]
49. ALKBH5 Inhibited Cell Proliferation and Sensitized Bladder Cancer Cells to Cisplatin by m6A-CK2α-Mediated Glycolysis. Yu H; Yang X; Tang J; Si S; Zhou Z; Lu J; Han J; Yuan B; Wu Q; Lu Q; Yang H Mol Ther Nucleic Acids; 2021 Mar; 23():27-41. PubMed ID: 33376625 [TBL] [Abstract][Full Text] [Related]
50. TMEM184B promotes proliferation, migration and invasion, and inhibits apoptosis in hypopharyngeal squamous cell carcinoma. Lin Y; Liu D; Li X; Ma Y; Pan X J Cell Mol Med; 2022 Nov; 26(21):5551-5561. PubMed ID: 36254814 [TBL] [Abstract][Full Text] [Related]
51. The RNA demethylase ALKBH5 promotes osteoblast differentiation by modulating Runx2 mRNA stability. Feng L; Fan Y; Zhou J; Li S; Zhang X FEBS Lett; 2021 Aug; 595(15):2007-2014. PubMed ID: 34105773 [TBL] [Abstract][Full Text] [Related]
52. ALKBH5 modulates macrophages polarization in tumor microenvironment of ovarian cancer. An Y; Duan H J Ovarian Res; 2024 Apr; 17(1):84. PubMed ID: 38637813 [TBL] [Abstract][Full Text] [Related]
53. ALKBH5-mediated m Hao L; Yin J; Yang H; Li C; Zhu L; Liu L; Zhong J Aging (Albany NY); 2021 Jan; 13(3):4045-4062. PubMed ID: 33428593 [TBL] [Abstract][Full Text] [Related]
54. Hypoxia induces the breast cancer stem cell phenotype by HIF-dependent and ALKBH5-mediated m⁶A-demethylation of NANOG mRNA. Zhang C; Samanta D; Lu H; Bullen JW; Zhang H; Chen I; He X; Semenza GL Proc Natl Acad Sci U S A; 2016 Apr; 113(14):E2047-56. PubMed ID: 27001847 [TBL] [Abstract][Full Text] [Related]
55. ALKBH5-Mediated m Liang H; Zhang C; Hu M; Hu F; Wang S; Wei W; Hu W Mol Carcinog; 2025 Jan; 64(1):57-71. PubMed ID: 39387829 [TBL] [Abstract][Full Text] [Related]
56. RNA Demethylase ALKBH5 Selectively Promotes Tumorigenesis and Cancer Stem Cell Self-Renewal in Acute Myeloid Leukemia. Shen C; Sheng Y; Zhu AC; Robinson S; Jiang X; Dong L; Chen H; Su R; Yin Z; Li W; Deng X; Chen Y; Hu YC; Weng H; Huang H; Prince E; Cogle CR; Sun M; Zhang B; Chen CW; Marcucci G; He C; Qian Z; Chen J Cell Stem Cell; 2020 Jul; 27(1):64-80.e9. PubMed ID: 32402250 [TBL] [Abstract][Full Text] [Related]
57. m Liu Y; Zhou T; Wang Q; Fu R; Zhang Z; Chen N; Li Z; Gao G; Peng S; Yang D J Cachexia Sarcopenia Muscle; 2022 Apr; 13(2):1210-1223. PubMed ID: 35142084 [TBL] [Abstract][Full Text] [Related]
58. RNA N6-methyladenosine reader IGF2BP2 promotes lymphatic metastasis and epithelial-mesenchymal transition of head and neck squamous carcinoma cells via stabilizing slug mRNA in an m6A-dependent manner. Yu D; Pan M; Li Y; Lu T; Wang Z; Liu C; Hu G J Exp Clin Cancer Res; 2022 Jan; 41(1):6. PubMed ID: 34980207 [TBL] [Abstract][Full Text] [Related]
59. HPV E7-drived ALKBH5 promotes cervical cancer progression by modulating m6A modification of PAK5. Huo FC; Zhu ZM; Du WQ; Pan YJ; Jiang X; Kang MJ; Liu BW; Mou J; Pei DS Pharmacol Res; 2023 Sep; 195():106863. PubMed ID: 37480971 [TBL] [Abstract][Full Text] [Related]
60. m Tsuchiya K; Yoshimura K; Iwashita Y; Inoue Y; Ohta T; Watanabe H; Yamada H; Kawase A; Tanahashi M; Ogawa H; Funai K; Shinmura K; Suda T; Sugimura H Cancer Gene Ther; 2022 Oct; 29(10):1355-1372. PubMed ID: 35318440 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]